D. Western Therapeutics Institute, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -83.31% vs -26.96% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -22.53% vs 20.75% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15.10",
          "val2": "90.50",
          "chgp": "-83.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-166.10",
          "val2": "-129.50",
          "chgp": "-28.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.20",
          "val2": "2.70",
          "chgp": "18.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-170.80",
          "val2": "-139.40",
          "chgp": "-22.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-11,066.90%",
          "val2": "-1,562.30%",
          "chgp": "-950.46%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -17.81% vs 10.08% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 51.01% vs -55.76% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "387.60",
          "val2": "471.60",
          "chgp": "-17.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-572.40",
          "val2": "-1,159.90",
          "chgp": "50.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.80",
          "val2": "5.20",
          "chgp": "69.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-60.60",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-632.10",
          "val2": "-1,290.30",
          "chgp": "51.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,599.20%",
          "val2": "-2,564.30%",
          "chgp": "96.51%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

15.10

90.50

-83.31%

Operating Profit (PBDIT) excl Other Income

-166.10

-129.50

-28.26%

Interest

3.20

2.70

18.52%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-170.80

-139.40

-22.53%

Operating Profit Margin (Excl OI)

-11,066.90%

-1,562.30%

-950.46%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -83.31% vs -26.96% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -22.53% vs 20.75% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

387.60

471.60

-17.81%

Operating Profit (PBDIT) excl Other Income

-572.40

-1,159.90

50.65%

Interest

8.80

5.20

69.23%

Exceptional Items

0.00

-60.60

100.00%

Consolidate Net Profit

-632.10

-1,290.30

51.01%

Operating Profit Margin (Excl OI)

-1,599.20%

-2,564.30%

96.51%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -17.81% vs 10.08% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 51.01% vs -55.76% in Dec 2024

All Annual Results